NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Allen Biotechnology Co ABC? Mail in a sample (US only) and let us test it.

Test my supply
+1 more ↓
63%
Finnrick rating
#396 of 500 ranked vendors
55 of 76 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Allen Biotechnology Co ABC's purity-focus record is broad but uneven, with Retatrutide the clearest strength and Tesamorelin improving after earlier purity misses. Tirzepatide is dented by a late identity failure, while BPC-157 and TB-500 remain weak; recent data helps, but missing batch IDs and dispersed results temper confidence.

methodology →
vendor intelligence report
Vendor Intelligence Report: Allen Biotechnology Co ABC

RDAP records and shared storefront templates trace Allen into a newer multi-brand network with an unverified ABT Labs LLC operator line. The dossier also follows conflicted COA claims, crypto-only payment rails, and cloaked institutional search pages redirecting peptide traffic.

34 pages10 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$1.10
88%
14
2
Tirzepatide
$0.33
74%
40
3
PT-141
$0.60
68%
4
4
Tesamorelin
$1.45
59%
9
5
BPC-157
-
41%
5
6
TB-500
$1.05
36%
4
7
Ipamorelin
$0.85
-
0
8
NAD+
-
-
0
9
SS-31
$0.60
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%4 Feb 2026: 53%4 Feb 2026: 52%4 Feb 2026: 53%4 Feb 2026: 53%11 Feb 2026: 54%11 Feb 2026: 54%15 Feb 2026: 55%16 Feb 2026: 55%18 Feb 2026: 55%18 Feb 2026: 54%18 Feb 2026: 54%18 Feb 2026: 54%18 Feb 2026: 53%19 Feb 2026: 53%20 Feb 2026: 54%20 Feb 2026: 53%25 Feb 2026: 54%25 Feb 2026: 54%26 Feb 2026: 55%26 Feb 2026: 55%1 Mar 2026: 56%1 Mar 2026: 56%2 Mar 2026: 57%4 Mar 2026: 61%4 Mar 2026: 61%6 Mar 2026: 61%6 Mar 2026: 61%12 Mar 2026: 62%23 Apr 2026: 62%23 Apr 2026: 61%28 Apr 2026: 62%11 May 2026: 62%11 May 2026: 62%4 Jun 2026: 63%12 Jun 2026: 63%26 Jun 2026: 63%17 Jul 2026: 63%3 Aug 2026: 63%6 Aug 2026: 63%6 Oct 2026: 62%17 Nov 2026: current 63%53%62%63%Feb 26Nov 26
Peptide testing

Ordered peptides from Allen Biotechnology Co ABC? Mail in a sample (US only) and let us test it.

Test my supply
Allen Biotechnology Co ABC test history
COA-backed lab tests
1-10 of 76

About Allen Biotechnology Co ABC test results from Finnrick

Allen Biotechnology Co ABC is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 76 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Allen Biotechnology Co ABC peptides in this dataset are BPC-157 (5 tests), PT-141 (4 tests) and Retatrutide (14 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 76 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from Allen Biotechnology Co ABC? Mail in a sample (US only) and let us test it.

Test my supply